Pre-Approval Access for Administration of Daratumumab Subcutaneously (SC) in Participants Who Are Unable to Receive Intravenous (IV) Daratumumab
Clinical trial NCT04264884 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04264884
- Sponsor
- Janssen Research & Development, LLC
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.